William D. Paiva, PhD
Founder and Manager of the Oklahoma Life Science Fund
PERSONAL EXPERIENCE
William D. Paiva, PhD, is the founder and manager of the Oklahoma Life Science Fund (OLSF). OLSF makes investments in diagnostic, device, service, and therapeutic firms. OLSF portfolio companies have attracted over $350 million in venture capital investment from regional and national venture capital firms, over $1 billion in corporate development monies, and the fund has realized five exits.
Through Dr. Paiva’s 20 year venture capital journey, he has also been a partner at Sevin Rosen Funds, a fund with over $2 billion under management across nine funds, and was a partner at Chisholm Private Capital Partners, a $100 million fund focused on healthcare and IT. Before his venture capital career, Dr. Paiva served as a management consultant for the Life Sciences Industry Group at Pittiglio Rabin Todd & McGrath, later acquired by PriceWaterhouseCoopers, where he consulted with the top five pharmaceutical companies on product-development and technology-management projects. He also served as an investment banking associate at JP Morgan in New York, providing strategic and investment banking advisory services to Fortune 100 healthcare companies.
Recently, Dr. Paiva stood up Oklahoma State University’s Center for Health Systems Innovation (CHSI). The Center is focused on transforming rural and Native America health through the implementation of innovative care delivery and IT solutions. Within CHSI, the Innovation arm focuses on improving rural health care by implementing new and innovative care delivery models as well as applying advanced analytics to the largest health care database which includes clinical information for over 63 million patients covering 16 years. The Implementation arm includes three areas for testing new models and tools developed through the innovation arm. Those include the Health Access Network, ROK-Net, and Rural Health Network.
Dr. Paiva holds a Ph.D. in molecular biology from the University of Oklahoma; an MBA from Dartmouth College’s Amos Tuck School of Business; a master’s degree in microbiology and immunology from the University of Oklahoma Health Science Center; and a BS in microbiology from the University of Oklahoma.